Cargando…
New Insights into Treating Early and Advanced Stage Diabetic Retinopathy
Diabetic retinopathy (DR) is the leading cause of preventable blindness in the working-age population. The disease progresses slowly, and we can roughly differentiate two stages: early-stage (ESDR), in which there are mild retinal lesions and visual acuity is generally preserved, and advanced-stage...
Autores principales: | Simó, Rafael, Hernández, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368971/ https://www.ncbi.nlm.nih.gov/pubmed/35955655 http://dx.doi.org/10.3390/ijms23158513 |
Ejemplares similares
-
Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2021) -
Genetics in Diabetic Retinopathy: Current Concepts and New Insights
por: Simó-Servat, Olga, et al.
Publicado: (2013) -
Advances in the Medical Treatment of Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2009) -
Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model
por: Bogdanov, Patricia, et al.
Publicado: (2022) -
Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy
por: Valverde, Angela M., et al.
Publicado: (2013)